Burns Clinical Trial
— DHAOfficial title:
DeepView Snapshot Handheld (DV-H) Comparison Study
NCT number | NCT06024512 |
Other study ID # | CLA-PR-03 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | June 13, 2023 |
Est. completion date | January 25, 2024 |
Verified date | August 2023 |
Source | SpectralMD |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
his study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate healing versus non-healing burn tissue. This device, if approved, is expected to give caregivers a better understanding of what parts of burn wounds will likely not heal on their own and as a tool used by the military in the field. This current study involves the collection of images over the course of your clinical treatment and follow-up according to your routine standard of care. The device will not be used to diagnose or prescribe treatment for your burn
Status | Completed |
Enrollment | 18 |
Est. completion date | January 25, 2024 |
Est. primary completion date | January 25, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 75 Years |
Eligibility | Inclusion Criteria: .Age >18 years and able to give informed consent or have a Legally Authorized Representative (LAR) able to do so; - Life expectancy > 6 months; - Thermal burn mechanism (flame, scald, or contact); - The Study Burn(s) occurred less than 72 hours prior to the time of first imaging; - Minimum burn wound size for patients is 0.5% TBSA per region - Have 2 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn; and Exclusion Criteria: - Patients will be excluded if any of the following conditions apply: - Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or joints; - Subject has burns involving > 50% total body surface area (TBSA); - Sepsis at the time of enrollment determined by diagnosis made by Principal Investigator or Sub-Investigator; - Immunosuppression/radiation/chemotherapy < 3 months prior to enrollment; - Concurrent use of investigational products with a known effect on the burn sites; and/or - Any condition that in the opinion of the Investigator may prevent compliance with the study requirements or compromise subject safety. |
Country | Name | City | State |
---|---|---|---|
United States | LSU Health New Orleans University Medical Center New Orleans | New Orleans | Louisiana |
Lead Sponsor | Collaborator |
---|---|
SpectralMD |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | DeepView Snapshot Handheld (DV-SSH) Comparison Study Protocol | The primary objective of this study is to demonstrate that the proposed SA-MSI sensor is equivalent or better than the current LC-MSI sensor.
To conduct this test, we will compare the performance of the burn assessment AI algorithm using the image sensor as input data to the same Algorithm using the lens cluster data as an input. |
3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Completed |
NCT05276869 -
Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
|
||
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06076031 -
Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing
|
N/A | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
Recruiting |
NCT04090424 -
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT03159182 -
Study of Silicone Material Inserts To Treat Burn Scars
|
N/A | |
Recruiting |
NCT02904941 -
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
|
N/A | |
Completed |
NCT02681757 -
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01437852 -
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
|
Phase 1 | |
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Completed |
NCT01061502 -
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
|
Phase 1/Phase 2 | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Terminated |
NCT00824681 -
Effect of Music Therapy on Families of Burn Patients
|
Phase 1 | |
Terminated |
NCT00634166 -
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
|
Phase 4 | |
Terminated |
NCT00464386 -
Continuous Glucose Monitoring (POC) in the ICU
|
N/A | |
Withdrawn |
NCT00216983 -
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
|
N/A |